MedPath

Sublingual Misoprostol Versus Manual Vacuum Aspiration for Treatment of Incomplete Abortion in Nigeria: A Randomized Control Study

Not Applicable
Completed
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202009857889210
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
212
Inclusion Criteria

All consenting women at the study centres with first-trimester incomplete abortion, confirmed by a trans-abdominal ultrasound scan of the uterus, were eligible for the study

Exclusion Criteria

Women with excessive vaginal bleeding, severe anaemia (Hb < 7.0g%), or suspected ectopic pregnancy were excluded from the study.
A history of allergy to prostaglandins,
Evidence of genital infection such as offensive vaginal discharge, uterine tenderness, and pyrexia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure was the incidence of complete uterine evacuation (complete abortion) after one week of treatment with single-dose sublingual misoprostol 400mcg or MVA.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures included incidence, types, and tolerability of treatment side effects as well as participants’ satisfaction with the treatment received
© Copyright 2025. All Rights Reserved by MedPath